NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

There is one thing I just dont understand. Where is Merck in all this? Why are they risking NWBO ending up becoming a runaway bride? Merck could have bought a call option placeholder in NWBO for as little as $300 million, which is the same amount for them as $ 20 is for you and me, by negotiating a first buyout for a certain PPS when certain milestones are being achieved. Or they could have already started a joint trial with NWBO with the same upfront payment under the condition that they have the right to use DCVAX in such a manner for the next 5 years blocking out all competition.

The point is no big pharma, Merck, has swooped in to block the competition in some creative way with a large pocket of cash this far. Why is that?